LYON, France--(BUSINESS WIRE)--Regulatory News :
ERYTECH Pharma (Paris:ERYP) (ADR:EYRYY) (Euronext Paris: ERYP & OTC US: EYRYY), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical needs, announces the upcoming presentation of three abstracts, at the American Association for Cancer Research (AACR) taking place in Philadelphia, PA, USA from 18 to 22 April 2015.
Help employers find you! Check out all the jobs and post your resume.
